XERS — Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
- Exchange: NASDAQ
- Employees: 394
- Website: https://www.xerispharma.com
Latest SEC filings for XERS
- 8-K — 2026-09-09
- 8-K — 2026-08-06
- 10-Q — 2026-08-06
- 8-K — 2026-07-17
- 3 — 2026-07-02
- 8-K — 2026-06-30
- 8-K — 2026-06-11
- 8-K — 2026-06-05
- 8-K — 2026-05-07
- 10-Q — 2026-05-07
Latest XERS news
- — Analyzing Xeris Biopharma (NASDAQ:XERS) and Corcept Therapeutics (NASDAQ:CORT)
- — Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- — Xeris Biopharma (NASDAQ:XERS) Shares Climb 5.2% – Here’s What Happened
- — Xeris Biopharma jumps on report of interest from H Lundbeck (seekingalpha_market)
- — Xeris Biopharma stock hits 52-week high at 10.08 USD By Investing.com - Investing.com UK (Investing.com UK)
- — Lundbeck expresses interest in buying Xeris, Bloomberg News reports (reuters.com)
- — A Xeris Biopharma (XERS) officer proposes a share sale valued at $637,000. - Stock Titan (Stock Titan)
- — (XERS) Risk Channels and Responsive Allocation - Stock Traders Daily (Stock Traders Daily)
- — Xeris Biopharma Holdings stock rises 6.65 percent on Nasdaq - ad-hoc-news.de (ad-hoc-news.de)
- — Gen Xers share 17 nostalgic dishes they ate growing up—and still make for dinner - Upworthy (Upworthy)
Educational tool only — not investment advice.